Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis

9 Dec 2021

Abstract excerpt

Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the virus's dynamicity has resulted in the evolution of various variants, including the delta variant and the more novel mu variant. With a multitude of mutant strains posing as challenges to vaccine efficacy, it is critical that researchers embrace the development of pharmacotherapeutics specific to SARS-CoV-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Share to Venous Thromboembolism Diagnosis and Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34944683
DOI: 10.3390/biomedicines9121867

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PAD Inhibitors as a Potential Treatment for SARS-CoV-2 ImmunothrombosisPMID 34944683Read ↗

Mechanisms of Immunothrombosis by SARS-CoV-2Semantic proximity Read ↗

Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4Semantic proximity Read ↗

Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19Semantic proximity Read ↗

Peptidylarginine Deiminase 2 in Host Immunity: Current Insights and PerspectivesSemantic proximity Read ↗

Neutrophil extracellular traps and macrophage activation contibute to thrombosis and post-covid syndrome in SARS-CoV-2 infectionSemantic proximity Read ↗

Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.Semantic proximity Read ↗

Are Aspirin and Apixaban Sufficient to Prevent Immunothrombosis in COVID-19?Semantic proximity Read ↗

Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and ThrombosisSemantic proximity Read ↗

PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritisSemantic proximity Read ↗

Treatment with anti-inflammatory viral serpin modulates immuno-thrombotic responses and improves outcomes in SARS-CoV-2 infected miceSemantic proximity Read ↗

<strong></strong><strong>COVID-19 Clot: What Is It? Why in the Lungs? Extracellular Histone, “Auto-Activation” of Prothrombin, Emperipolesis, Megakaryocytes, “Self-Association” of Von Willebrand Factor and Beyond</strong>Semantic proximity Read ↗

Complement Inhibition and COVID-19: The Story so FarSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.